Home
Stocks Trading
Analyst Snapshot
Financial Scores
Market Summary

SYRE Shares

What is SYRE’s price-to-sales ratio telling us about the company’s value?

January 5, 2026

Arcelia Reed

Currently, Spyre Therapeutics Inc’s (SYRE) stock is trading at $28.17, marking a fall of -7.88% from last night’s close. At ...

Most Recent

Analyst Snapshot

Will TripAdvisor Inc (TRIP) beat or miss earnings estimates this quarter?

Stocks Trading

MOH’s earnings estimates: Are they on track to meet expectations?

Market Summary

What to expect from FG’s earnings report this quarter?

Financial Scores

Predicting Rush Street Interactive Inc’s (RSI) earnings for the current quarter

Analyst Snapshot

AGRO’s Q2 earnings predictions: What the experts say

Stocks Trading

How will Slide Insurance Holdings Inc’s (SLDE) earnings compare to estimates this quarter?

Who We Are

Fueled by a passion for truth since 1992, US Post News brings you trustworthy journalism. Our team of investigators, photographers, and writers delivers fresh news you can rely on. We started with ink and screens, but today we’re a web leader, illuminating the world with verified information.

Company

About US
Contact Us
Disclaimer
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled